Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study.

Larock AS, Mullier F, Sennesael AL, Douxfils J, Devalet B, Chatelain C, Dogné JM, Spinewine A.

Ann Pharmacother. 2014 Oct;48(10):1258-68. doi: 10.1177/1060028014540868. Epub 2014 Jun 30.

PMID:
24982310
[PubMed - indexed for MEDLINE]
2.

Dabigatran, intracranial hemorrhage, and the neurosurgeon.

Awad AJ, Walcott BP, Stapleton CJ, Yanamadala V, Nahed BV, Coumans JV.

Neurosurg Focus. 2013 May;34(5):E7. doi: 10.3171/2013.2.FOCUS1323. Review.

PMID:
23634926
[PubMed - indexed for MEDLINE]
3.

Dabigatran etexilate: management in acute ischemic stroke.

Javedani PP, Horowitz BZ, Clark WM, Lutsep HL.

Am J Crit Care. 2013 Mar;22(2):169-76. doi: 10.4037/ajcc2013125.

PMID:
23455868
[PubMed - indexed for MEDLINE]
Free Article
4.

Management of atrial fibrillation: direct factor IIa and Xa inhibitors or "warfarin shotgun"?

Halperin JL, Goyette RE.

Mt Sinai J Med. 2012 Nov-Dec;79(6):705-20. doi: 10.1002/msj.21346. Review.

PMID:
23239209
[PubMed - indexed for MEDLINE]
5.

Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.

Sangha N, El Khoury R, Misra V, Lopez G.

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):917.e5-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.05.003. Epub 2012 Jun 9.

PMID:
22683118
[PubMed - indexed for MEDLINE]
6.

Dabigatran: a new anticoagulant for stroke prevention in patients with atrial fibrillation.

Weachter R.

Mo Med. 2012 Mar-Apr;109(2):146-9.

PMID:
22675797
[PubMed - indexed for MEDLINE]
7.

Antithrombotic medication for cardioembolic stroke prevention.

Font MÀ, Krupinski J, Arboix A.

Stroke Res Treat. 2011;2011:607852. doi: 10.4061/2011/607852. Epub 2011 Jun 22.

PMID:
21822469
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk